Skip to content

Monitoring fetal-to-neonatal pulmonary transition after birth with transcutaneous electromyography of the diaphragm

Monitoring fetal-to-neonatal pulmonary transition after birth with transcutaneous electromyography of the diaphragm - BRAHMS - Transition

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON48881
Enrollment
30
Registered
2018-06-08
Start date
2018-07-27
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary transition respiratory distress

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: -Infants who are born,older than 26 weeks, and need monitoring of the pulmonary transition -Written parental informed consent acquired antenatal or deferred.

Exclusion criteria

Exclusion criteria: - Major congenital anomaly that prevents placement of EMG electrodes - Patients for whom life support will be witheld or withdrawn at birth will not be included

Design outcomes

Primary

MeasureTime frame
The feasibility of dEMG - recording in the delivery room (Signal quality of dEMG) during pulmonary transition expressed as the accuracy in heart rate and respiratory rate.

Secondary

MeasureTime frame
Secondary endpoints are: - Description of changes in electrical activity (peak, amplitude, tonic activity, etc.) of the diaphragm during the transition. - Comparison in timing of heart rate detection acquired by EMG, compared to CI and PO, in order to find out which method is the fastest in detecting heart rate - Besides heart rate monitoring and breathing monitoring, other parameters from the standard-of-care respiratory function monitor (RFM) are studied as well in order to investigate the effect of respiratory support on diaphragmatic activity.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)